Miriam Kim, MD

Miriam Kim, MD

Medical Oncologist

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Clinical Expertise

Leukemia

Research Interest

Developing genetically modified T cells for therapy of acute myeloid leukemia

Education

  • 2008: MD, Seoul National University, South Korea

Training

  • 2008 - 2011: Resident, internal medicine, SUNY Downstate Medical Center, Brooklyn, New York
  • 2011 - 2014: Fellow, hematology and oncology, University of Southern California, Los Angeles
  • 2014 - 2017: Postdoctoral researcher, University of Pennsylvania, Philadelphia

Board Certification

  • 2011: American Board of Internal Medicine
  • 2014: American Board of Internal Medicine - hematology
  • 2014: American Board of Internal Medicine - oncology

Selected Research Publications

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
  • Xiang J, Devenport JM, Carter AJ, [...] Kim MY, [...] DiPersio JF
  • Leukemia 2023
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
  • Rimando JC, Chendamarai E, Rettig MP, [...] Kim M, [...] DiPersio JF
  • Blood 2023
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Kim MY, [...] Welch JS
  • Haematologica 2022
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.
  • Kim MY, Cooper ML, Jacobs MT, [...] DiPersio JF
  • JCI Insight 2021

View All Publications

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

Phone Numbers

Request an appointment